InvestorsHub Logo
Followers 3
Posts 277
Boards Moderated 0
Alias Born 12/21/2022

Re: None

Monday, 05/29/2023 10:31:01 AM

Monday, May 29, 2023 10:31:01 AM

Post# of 3283
HC Wainwright issued their Q3 2023 earnings per share estimates for Spectrum Pharmaceuticals in a research note issued on Friday, May 26th. HC Wainwright analyst E. White expects that the biotechnology company will earn $0.01 per share for the quarter. So, in Q3 they will be profitable but won't exist as an independent company.